Department of Physiology, Medical Science College of China Three Gorges University, Yichang, China.
Life Sci. 2011 Jun 6;88(23-24):1026-30. doi: 10.1016/j.lfs.2011.03.011. Epub 2011 Apr 5.
To investigate the role of the mitochondrial Ca(2+)-activated K(+) channel in cardioprotection induced by limb remote ischemic preconditioning.
Male Sprague-Dawley rats (250-300 g) were randomized into control, ischemia/reperfusion (I/R), remote ischemic preconditioning (RPC), NS1619 (a specific mitochondrial Ca(2+)-activated K(+) channel opener), and RPC+paxilline (a specific mitochondrial Ca(2+)-activated K(+) channel inhibitor) groups. RPC was induced by 4 cycles of 5 min of ligation followed by 5 min of reperfusion of the left femoral artery. Myocardial I/R was achieved by ligation of the left anterior descending coronary artery for 30 min, followed by 120 min of reperfusion. Infarct size was determined by 2,3,5-triphenyltetrazolium chloride staining, the hemodynamics were monitored, and lactate dehydrogenase (LDH) levels in the coronary effluent, manganese superoxide dismutase (Mn-SOD) content in mitochondria and mitochondrial membrane potential were measured spectrophotometrically. The ultrastructure of cardiomyocyte mitochondria was assessed by electron microscopy.
NS1619 (10 μM) improved heart function, decreased infarct size, reduced LDH release, maintained mitochondrial structural integrity and mitochondrial membrane potential, and increased the mitochondrial content of Mn-SOD to the same degree as RPC treatment. However, paxilline (1 μM) eliminated the cardioprotective effect conferred by RPC.
The mitochondrial Ca(2+)-activated K(+) channel participates in the myocardial protection by limb remote ischemic preconditioning.
研究线粒体钙激活钾通道在肢体远程缺血预处理诱导的心脏保护中的作用。
雄性 Sprague-Dawley 大鼠(250-300 g)随机分为对照组、缺血/再灌注(I/R)组、远程缺血预处理(RPC)组、NS1619(一种特异性线粒体钙激活钾通道开放剂)组和 RPC+巴卡丁(一种特异性线粒体钙激活钾通道抑制剂)组。RPC 通过结扎左股动脉 4 个循环(5 分钟结扎,5 分钟再灌注)来诱导。通过结扎左前降支冠状动脉 30 分钟,再灌注 120 分钟来实现心肌 I/R。通过 2,3,5-三苯基四氮唑氯化物染色来确定梗死面积,通过监测血流动力学和测定冠状流出液中的乳酸脱氢酶(LDH)水平、分光光度法测定线粒体中锰超氧化物歧化酶(Mn-SOD)含量和线粒体膜电位来测量。通过电子显微镜评估心肌细胞线粒体的超微结构。
NS1619(10 μM)改善了心功能,减少了梗死面积,减少了 LDH 释放,维持了线粒体结构的完整性和线粒体膜电位,并使线粒体中 Mn-SOD 的含量增加到与 RPC 处理相同的程度。然而,巴卡丁(1 μM)消除了 RPC 赋予的心脏保护作用。
线粒体钙激活钾通道参与了肢体远程缺血预处理的心肌保护作用。